CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 120 enrolled
Drug / intervention
Stannous Fluoride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01592864
NCT01592864Phase 3Completed
CompareCT.gov

A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity

GlaxoSmithKline·interventional·Posted May 7, 2012·Updated Mar 10, 2014

In Brief

A Phase 3 clinical trial evaluating Stannous Fluoride and Sodium Monofluorophosphate for Dentine Hypersensitivity. Completed, enrolled 120 participants across 1 site.

Detailed Summary

A study to compare the efficacy of a test dentifrice against a control dentifrice in reducing dentinal hypersensitivity over an eight week treatment period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentine Hypersensitivity
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 7, 2012
Enrollment StartMar 1, 2012
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 14.2 years ago

Interventions

Stannous Fluoridedrug

dentifice

Sodium Monofluorophosphatedrug

dentifrice